Rna Diagnostics is a Canadian company with a patented platform technology providing real-time cancer therapy guidance.
Rna Diagnostics is an early-stage molecular diagnostics company developing medical diagnostic tools to assist in the management of cancer. The company's first product, the RNA Disruption AssayTM (RDATM), is a novel test that helps oncologists rapidly assess the effectiveness of cancer chemotherapy.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jul 26, 2019 | Series A | — | 1 | — | — | Detail |
Nov 9, 2018 | Series A | $5M | 1 | iGan Partners | — | Detail |
Jan 15, 2016 | Angel | — | 3 | — | — | Detail |
Sep 21, 2015 | Angel | $800K | — | — | — | Detail |
Mar 27, 2012 | Angel | $0.92M | 7 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
iGan Partners | Yes | Series A |
MEDTEQ+ | — | Series A |
Northern Ontario Angels | — | Angel |
Ontario Centres of Excellence | — | Angel |
York Angels Investors | — | Angel |
Niagara Angel Network | — | Angel |
Natacor Inc. | — | Angel |
Angel One Network | — | Angel |
Anges Quebec | — | Angel |
Georgian Angel Network | — | Angel |